Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

Cardiovascular DiseasesInflammationAging

Interventions

OTHER

Placebo

Placebo injection at day one and day fourteen.

DRUG

Abatacept 10 mg/kg

Abatacept injection at day twenty eight and day forty two.

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Utah

OTHER